MetLife, Inc. $MET Position Lifted by Focus Advisor Solutions LLC

Focus Advisor Solutions LLC grew its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 149.2% in the third quarter, HoldingsChannel reports. The fund owned 32,413 shares of the financial services provider’s stock after purchasing an additional 19,405 shares during the quarter. Focus Advisor Solutions LLC’s holdings in MetLife were worth $3,052,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. OneAscent Family Office LLC bought a new position in shares of MetLife in the third quarter worth about $277,000. Meeder Asset Management Inc. grew its stake in shares of MetLife by 156.5% during the 3rd quarter. Meeder Asset Management Inc. now owns 354 shares of the financial services provider’s stock valued at $33,000 after acquiring an additional 216 shares during the period. Composition Wealth LLC grew its stake in shares of MetLife by 9.4% during the 3rd quarter. Composition Wealth LLC now owns 7,424 shares of the financial services provider’s stock valued at $699,000 after acquiring an additional 637 shares during the period. Public Sector Pension Investment Board increased its holdings in MetLife by 50.5% in the 3rd quarter. Public Sector Pension Investment Board now owns 232,233 shares of the financial services provider’s stock worth $23,344,000 after acquiring an additional 77,912 shares in the last quarter. Finally, Global Retirement Partners LLC increased its holdings in MetLife by 14.3% in the 3rd quarter. Global Retirement Partners LLC now owns 16,952 shares of the financial services provider’s stock worth $1,596,000 after acquiring an additional 2,120 shares in the last quarter. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have commented on MET shares. Piper Sandler raised their target price on shares of MetLife from $110.00 to $115.00 and gave the stock an “overweight” rating in a research note on Monday, November 9th. Argus upped their price target on shares of MetLife from $93.00 to $109.00 and gave the stock a “buy” rating in a research report on Wednesday, September 2nd. Keefe, Bruyette & Woods increased their price objective on shares of MetLife from $105.00 to $108.00 and gave the stock an “outperform” rating in a research note on Tuesday, August 11th. UBS Group raised their price objective on shares of MetLife from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Tuesday, October 6th. Finally, TD Cowen lifted their target price on shares of MetLife from $110.00 to $114.00 and gave the company a “buy” rating in a research note on Wednesday, October 21st. Fourteen investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, MetLife has an average rating of “Moderate Buy” and a consensus target price of $107.12.

Read Our Latest Report on MetLife

Insider Buying and Selling at MetLife

In related news, CEO Michel Khalaf sold 187,425 shares of the company’s stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $102.97, for a total transaction of $19,299,152.25. Following the completion of the transaction, the chief executive officer owned 759,013 shares in the company, valued at approximately $78,155,568.61. This represents a 19.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.40% of the company’s stock.

MetLife Stock Down 2.1%

Shares of MET opened at $95.59 on Friday. The business’s 50 day moving average is $99.02 and its 200 day moving average is $87.43. The company has a current ratio of 0.21, a quick ratio of 0.21 and a debt-to-equity ratio of 0.65. MetLife, Inc. has a 12-month low of $67.33 and a 12-month high of $106.72. The company has a market capitalization of $60.07 billion, a PE ratio of 12.46, a price-to-earnings-growth ratio of 0.90 and a beta of 0.79.

MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The financial services provider reported $2.78 earnings per share for the quarter, topping the consensus estimate of $2.77 by $0.01. MetLife had a return on equity of 25.71% and a net margin of 6.21%. The business had revenue of $20.52 billion during the quarter, compared to the consensus estimate of $19.86 billion. During the same period in the prior year, the company posted $2.34 EPS. The firm’s revenue for the quarter was up 18.2% compared to the same quarter last year. Research analysts expect that MetLife, Inc. will post 9.94 earnings per share for the current fiscal year.

MetLife Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Stockholders of record on Tuesday, November 3rd will be issued a $0.5925 dividend. This represents a $2.37 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend is Tuesday, November 3rd. MetLife’s payout ratio is 30.90%.

MetLife announced that its Board of Directors has approved a stock repurchase program on Wednesday, August 5th that authorizes the company to buy back $3 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to reacquire up to 4.8% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its shares are undervalued.

About MetLife

(Free Report)

MetLife, Inc. is a global financial services company best known for providing insurance, employee benefits and retirement-related products. Its offerings include life, dental and disability insurance, annuities, and products and services designed to help individuals and employers plan for financial protection and retirement. The company serves individuals, businesses and institutions in the United States and international markets, including countries in Latin America, Asia, Europe and the Middle East.

Featured Articles

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.